Romero, J. C., Tonapi, S. S., Parihar, M., Loranc, E., Miller, H. E., Lawrence, L. A., Bassani, N., Robledo, D. G., Cao, L., Nie, J., Kanda, K., Stoja, A., Garcia, N., Gorthi, A., Stoveken, B. J., Fan, T. W.-M., Cassel, T. A., Zha, S., Lechleiter, J. D., … Bishop, A. J. R. (2025). Loss of CD98HC phosphorylation by ATM impairs antiporter trafficking and drives glutamate toxicity in Ataxia telangiectasia. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-60304-4

Gangwar, S. P., Yelshanskaya, M. V., Nadezhdin, K. D., Yen, L. Y., Newton, T. P., Aktolun, M., Kurnikova, M. G., & Sobolevsky, A. I. (2024). Kainate receptor channel opening and gating mechanism. Nature, 630(8017), 762–768. https://doi.org/10.1038/s41586-024-07475-0

Biswas, S., Shahriar, S., Bachay, G., Arvanitis, P., Jamoul, D., Brunken, W. J., & Agalliu, D. (2024). Glutamatergic neuronal activity regulates angiogenesis and blood-retinal barrier maturation via Norrin/β-catenin signaling. Neuron, 112(12), 1978-1996.e6. https://doi.org/10.1016/j.neuron.2024.03.011

Lin, X., Fisher, N. M., Dogra, S., Senter, R. K., Reed, C. W., Kalbfleisch, J. J., Lindsley, C. W., Asher, W. B., Xiang, Z., Niswender, C. M., & Javitch, J. A. (2022). Differential activity of mGlu7 allosteric modulators provides evidence for mGlu7/8 heterodimers at hippocampal Schaffer collateral-CA1 synapses. Journal of Biological Chemistry, 298(10), 102458. https://doi.org/10.1016/j.jbc.2022.102458

Li Puma, D. D., Ripoli, C., Puliatti, G., Pastore, F., Lazzarino, G., Tavazzi, B., Arancio, O., Piacentini, R., & Grassi, C. (2022). Extracellular tau oligomers affect extracellular glutamate handling by astrocytes through downregulation of GLT‐1 expression and impairment of NKA1A2 function. Neuropathology and Applied Neurobiology, 48(5). Portico. https://doi.org/10.1111/nan.12811

Reyes-Madrigal, F., Guma, E., León-Ortiz, P., Gómez-Cruz, G., Mora-Durán, R., Graff-Guerrero, A., Kegeles, L. S., Chakravarty, M. M., & de la Fuente-Sandoval, C. (2022). Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 113, 110473. https://doi.org/10.1016/j.pnpbp.2021.110473

Basavaraju, R., Guo, J., Small, S. A., Lieberman, J. A., Girgis, R. R., & Provenzano, F. A. (2022). Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis. JAMA Psychiatry, 79(2), 178. https://doi.org/10.1001/jamapsychiatry.2021.3710

Saucisse, N., Mazier, W., Simon, V., Binder, E., Catania, C., Bellocchio, L., Romanov, R. A., Léon, S., Matias, I., Zizzari, P., Quarta, C., Cannich, A., Meece, K., Gonzales, D., Clark, S., Becker, J. M., Yeo, G. S. H., Fioramonti, X., Merkle, F. T., … Cota, D. (2021). Functional heterogeneity of POMC neurons relies on mTORC1 signaling. Cell Reports, 37(2), 109800. https://doi.org/10.1016/j.celrep.2021.109800